Sponsors

Statistical quality control: an overview of monitoring process with rules

In this sixth article in a series on internal quality control, Stephen MacDonald moves on from the detection of potentially medically important errors, to focus this month on the rules applied to monitor the control of assay performance.

In the previous article in this series (June, page 21) we associated required performance with the complexity of control required. Complexity is determined by the application of rules. Every rule is triggered by a particular pattern of results and thereby detects error we need to control – either random or systematic, but not both. Here, we compare single and multiple rule approaches.

Rules are often described as warning, rejection or investigate further. Rejection rules are simple to understand. If they are breached, the process must be stopped. In the past, compliance to the 12S rule was satisfactory. Further investigation was not required. Nowadays, further investigation can be instigated before rules are breached. This is particularly true for trend and systematic shift rules that use multiple sequential runs and allows the scientist to identify whether there is an issue prior to the actual alarm.

            The simplest and most familiar of all rules is the 12S rule. An internal quality control (IQC) result exceeding ±2 standard deviations (SD) from the target mean will trigger the alarm (Table 1). This is a measure of increased imprecision in the system and therefore random error. Taken alone, there is a 5% probability of a false-positive alarm. This non-specificity can be mitigated by increasing the limit to 3S. By reducing the false-positive rate to below 1%, this significantly improves its specificity for a genuine error, but this in itself introduces concerns of clinically relevant errors being undetected. Equally, a 22S rule will increase the specificity of detecting a genuine shift in the process – this time suggesting a systematic change. This sacrifices the detection of increased imprecision.

Log in or register FREE to read the rest

This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text. If you don't already have an account, please register with us completely free of charge.

Latest Issues

Association for Molecular Pathology (AMP) 2024 Annual Meeting & Expo

Hyatt Regency, Vancouver, Canada
19-23 November, 2024

11th Digital Pathology & AI Congress: Europe

Hilton London Metropole, 255 Edgware Road, London, W2 1JU
11-12 December, 2024

Microbiology Society Annual Conference 2025

Liverpool Arena and Convention Centre
31 March - 3 April, 2025

BSMT Annual Microbiology Conference

RAF Museum, Hendon, London NW9 5LL
15 May, 2025

Ghent Pathology 2025

ICC Ghent, Belgium
24-26 June, 2025